Virtu Financial LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 33,807 shares of the company’s stock, valued at approximately $3,043,000. Virtu Financial LLC owned about 0.32% of Direxion Daily S&P Biotech Bull 3x Shares at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of LABU. Dunhill Financial LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter valued at approximately $46,000. Spire Wealth Management purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter valued at approximately $68,000. B. Riley Wealth Advisors Inc. purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter valued at approximately $279,000. SBI Securities Co. Ltd. purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter valued at approximately $244,000. Finally, SG Americas Securities LLC increased its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 6.0% during the 4th quarter. SG Americas Securities LLC now owns 3,392 shares of the company’s stock valued at $305,000 after purchasing an additional 193 shares in the last quarter.
Direxion Daily S&P Biotech Bull 3x Shares Stock Up 1.5 %
NYSEARCA:LABU opened at $76.39 on Friday. The company has a 50 day moving average price of $85.73 and a 200-day moving average price of $107.08. Direxion Daily S&P Biotech Bull 3x Shares has a 1-year low of $69.61 and a 1-year high of $152.60.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
See Also
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- What is a Dividend King?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Stock Market Sectors: What Are They and How Many Are There?
- Micron Stock Will Retest All-Time Highs This Year
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
